Radnor, PA, United States of America

Audrey E Baker

USPTO Granted Patents = 1 


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 832,891 
Other
 patents

Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celebrating the Innovations of Audrey E. Baker in GLP-2 Research

Introduction: Audrey E. Baker, an accomplished inventor based in Radnor, Pennsylvania, has made significant contributions to the field of biomedical research. With a unique focus on GLP-2 mimetibodies and their applications, Baker’s work holds promise for treating various GLP-2 related diseases.

Latest Patents: Audrey E. Baker is credited with one patent that stands out in her portfolio: the development of GLP-2 mimetibodies, polypeptides, compositions, methods, and their uses. This patent discloses mammalian GLP-2 mimetibodies, polypeptides, and nucleic acids, alongside methods for utilizing these innovations to combat health issues associated with GLP-2.

Career Highlights: Throughout her career, Baker has demonstrated a dedication to advancing medical research through her innovative approach. Her patent reflects not only her technical expertise but also her passion for improving healthcare outcomes.

Collaborations: In her journey, Audrey E. Baker has collaborated with esteemed colleagues such as Beverly A. Moore and Thomas Nesspor. These collaborations underscore her ability to work effectively within a team to innovate and push the boundaries of scientific research.

Conclusion: Audrey E. Baker's contributions to the field of GLP-2 research exemplify the power of innovation in addressing critical health challenges. Her work serves as an inspiration for future inventors and researchers striving to make a difference in the medical community. The advancements brought forth by her patent have the potential to transform treatment options and improve patient lives globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…